IL135513A0 - Use of thiazolidinediones for the treatment of hyperglycaemia - Google Patents

Use of thiazolidinediones for the treatment of hyperglycaemia

Info

Publication number
IL135513A0
IL135513A0 IL13551398A IL13551398A IL135513A0 IL 135513 A0 IL135513 A0 IL 135513A0 IL 13551398 A IL13551398 A IL 13551398A IL 13551398 A IL13551398 A IL 13551398A IL 135513 A0 IL135513 A0 IL 135513A0
Authority
IL
Israel
Prior art keywords
hyperglycaemia
thiazolidinediones
treatment
Prior art date
Application number
IL13551398A
Other languages
English (en)
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of IL135513A0 publication Critical patent/IL135513A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL13551398A 1997-10-13 1998-10-12 Use of thiazolidinediones for the treatment of hyperglycaemia IL135513A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9721693.1A GB9721693D0 (en) 1997-10-13 1997-10-13 Novel treatment
PCT/GB1998/003064 WO1999018943A1 (en) 1997-10-13 1998-10-12 Use of thiazolidinediones for the treatment of hyperglycaemia

Publications (1)

Publication Number Publication Date
IL135513A0 true IL135513A0 (en) 2001-05-20

Family

ID=10820482

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13551398A IL135513A0 (en) 1997-10-13 1998-10-12 Use of thiazolidinediones for the treatment of hyperglycaemia

Country Status (24)

Country Link
EP (1) EP1023056A1 (no)
JP (1) JP2001519382A (no)
KR (1) KR20010024481A (no)
CN (1) CN1281359A (no)
AP (1) AP2000001787A0 (no)
AU (1) AU9547098A (no)
BG (1) BG104404A (no)
BR (1) BR9815219A (no)
CA (1) CA2306086A1 (no)
CZ (1) CZ20001297A3 (no)
EA (1) EA002659B1 (no)
GB (1) GB9721693D0 (no)
HR (1) HRP20000255A2 (no)
HU (1) HUP0003922A3 (no)
ID (1) ID24521A (no)
IL (1) IL135513A0 (no)
NO (1) NO20001898L (no)
NZ (1) NZ503862A (no)
OA (1) OA11683A (no)
PL (1) PL339813A1 (no)
SK (1) SK5312000A3 (no)
TR (1) TR200000958T2 (no)
WO (1) WO1999018943A1 (no)
YU (1) YU28800A (no)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3856378T2 (de) * 1987-09-04 2000-05-11 Beecham Group Plc Substituierte Thiazolidindionderivate
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
US5478852C1 (en) * 1993-09-15 2001-03-13 Sankyo Co Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of impaired glucose tolerance in order to prevent or delay the onset of noninsulin-dependent diabetes mellitus

Also Published As

Publication number Publication date
NO20001898L (no) 2000-06-09
SK5312000A3 (en) 2000-09-12
EA200000419A1 (ru) 2000-10-30
HUP0003922A2 (hu) 2001-10-28
BG104404A (bg) 2000-12-29
NZ503862A (en) 2003-01-31
OA11683A (en) 2005-01-12
TR200000958T2 (tr) 2000-08-21
CA2306086A1 (en) 1999-04-22
CN1281359A (zh) 2001-01-24
WO1999018943A1 (en) 1999-04-22
EA002659B1 (ru) 2002-08-29
AP2000001787A0 (en) 2000-06-30
GB9721693D0 (en) 1997-12-10
PL339813A1 (en) 2001-01-02
EP1023056A1 (en) 2000-08-02
BR9815219A (pt) 2001-01-02
NO20001898D0 (no) 2000-04-12
JP2001519382A (ja) 2001-10-23
AU9547098A (en) 1999-05-03
YU28800A (sh) 2003-02-28
HUP0003922A3 (en) 2001-12-28
CZ20001297A3 (cs) 2001-08-15
KR20010024481A (ko) 2001-03-26
ID24521A (id) 2000-07-20
HRP20000255A2 (en) 2001-02-28

Similar Documents

Publication Publication Date Title
GB2321719B (en) Liquid treatment
EP0703282A3 (en) Surface treatment composition
HUP0002030A3 (en) Use of glur5 receptorantagonists for the treatment of pain
AU1542895A (en) Surface treatment
AU4774597A (en) Use of 1-hydroxy-2-pyridones for the treatment of skin infections
AU7310896A (en) Use of nitroflavonoids for the treatment of anxiety
EP0860867A4 (en) SURFACE TREATMENT FOR MICRO-MACHINING
AU3124295A (en) Surface treatment techniques
GB9511214D0 (en) Surface treatment
EP0755255A4 (en) TREATMENT OF TOXOPLASMOSIS
GB2304286B (en) Biocidal hard surface treatment
IL130831A0 (en) Imino-aza-anthracylinone derivatives for the treatment of amyloidosis
IL123530A0 (en) Procedure for the surface treatment of petrous materials
GB2355006B (en) Materials treatment
AP2000001788A0 (en) Use of thiazolidinediones for the treatment of hyperglycaemia
GB9416410D0 (en) Effluent treatment
GB9726223D0 (en) The treatment of materials
IL135513A0 (en) Use of thiazolidinediones for the treatment of hyperglycaemia
GB9717451D0 (en) Apparatus for treatment of surfaces
AUPO458197A0 (en) Synthetic surface treatment apparatus
GB2331514B (en) Effluent treatment
GB9611315D0 (en) Treatment of painted surfaces
AU5203898A (en) Synthetic surface treatment apparatus
GB9605961D0 (en) Surface treatment
GB9615469D0 (en) Surface treatment